Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
194M
-
Number of holders
-
446
-
Total 13F shares, excl. options
-
173M
-
Shares change
-
-885K
-
Total reported value, excl. options
-
$14.6B
-
Value change
-
+$51.1M
-
Put/Call ratio
-
0.94
-
Number of buys
-
228
-
Number of sells
-
-173
-
Price
-
$84.55
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q4 2019
548 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q4 2019.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 446 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 173M shares
of 194M outstanding shares and own 89.34% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (22M shares), VANGUARD GROUP INC (16.5M shares), PRIMECAP MANAGEMENT CO/CA/ (16.3M shares), BlackRock Inc. (13.1M shares), BAKER BROS. ADVISORS LP (7.59M shares), JENNISON ASSOCIATES LLC (7.04M shares), Clearbridge Investments, LLC (6.2M shares), STATE STREET CORP (4.91M shares), Dodge & Cox (4.39M shares), and AMERIPRISE FINANCIAL INC (3.2M shares).
This table shows the top 446 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.